Category Archives: The Speck

Moderna, Collapse & Class Action

October 27, 2024 By in Biotech, MRNA, Speck-Effect, The Speck

Just As Forecast

Moderna, MRNA, is down -88%, from its all-time highs.

Having worked the markets for nearly forty-years, it (typically) goes as follows …

When a stock declines 80% or more, in short order (12-36 months or so), those with absolutely no analysis skills or discipline, who bought-in because everyone else is doing it (making a supposed fortune), have now lost their shirts.

So, they do what they know best, blame somebody else. Let the lawsuits begin.

The whole thing is so much like High School.

Class action is nothing new. What is new this time around, or what could be new, is the ‘discovery’ process.

One has to wonder if (or when) the lawyers are going to come across this piece of ‘discovery’.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Gold … Measured Moves

October 19, 2024 By in Charles Hugh Smith, GLD, Gold & Silver, Gold Miners, Gold Production, Speck-Effect, Statista, The Speck Tags: , , ,

Is This … ‘Inflation?‘

Is gold rising because of ‘inflation’ or just another market going through pattern-influenced moves?

Maybe there’s something else, something no-one talks about.

As far as known, the following insight (first discussed here) is exclusive:

Since 2020, world-wide gold output is declining; output for 2023, down over 9%, since 2019, link here.

Could this be a clue? Full article is here.

Well, enough of the truth.

Let’s get back to our fantasy world; the highly simplistic excuse that gold’s responding to ‘massive inflation’ and ‘money printing’.

Gold GLD, Monthly

One wedge, with its target already reached.

There’s another potential wedge (not advice, not a recommendation).

Since futures are trading about $200/oz. higher than GLD (at 1/10 oz. pricing), the second measured move if reached, corresponds to about $3,300/oz. (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Usual Suspects

June 16, 2024 By in Artificial Intelligence, Federal Reserve, Food Supply, Genesis 41, Interest Rates, James Grant, The Speck, Usual Suspects, Wyckoff, ZeroHedge 1 Comment

Can It Get Any More Stupid?

It’s been a while since rounding up The Usual Suspects.

However, like last time, the stupidity, misdirection, misinformation, outright falsehoods, overall grift and schtick, has got to the point where an update is needed.

We’ll start off by repeating No. 1 from the prior ‘suspects’ as it encompasses the whole genre of ‘non-thought’ by the public and financial press alike; readers of this post excepted, of course. 🙂

No 1. There (still) is no Fed Pivot. Seriously, have rates really, actually been lowered? Everyone has a huge case of ‘normalcy bias’. i.e., what the Fed did last time will happen this time.

The 40-year bond bull market from the ’80s, ended in 2020. We’re in a different paradigm now.

We’ll add in this updated post, James Grant, of Grant’s Interest Rate Observer.

He second’s the motion: The 40-year bond bull market, is over. Period.

No 2. It has always been about the food supply.

Food is boring and gets no ‘clicks’ on my grifting ‘silver, gold stacking’ website or YouTube, so I ignore it.

After all, my business, is to get more business.

Just a reminder, if anyone really wants (inedible) gold or silver (cheap), this might be a way to get it.

No 3. The market has ‘thinned out’ to an incredible degree.

Now, instead of The Mag 7, there are only three and one of them, is a washed-up gaming stock.

How apropos, when considering the opening paragraphs about the overall public and financial press.

No 4. Is Artificial Intelligence just another lie?

Looks like according to this, it can’t be trusted. Who could have guessed?

I’m shocked! Shocked!

No 5. Ruh-Roh Scooby, fake meat’s bad for your health.

Didn’t see that one coming.

No 6. Well, there could be a new ‘scarient‘ in the works.

However, looking at price action of the biotech sector, far below its all-time highs, the market itself, is saying ‘No, not this time.’

No 7. Could the S&P make it to 6,300?

After all, it’s all about the numbers, right?

The S&P bottomed at 666.67 on 3/9/09.

Summary

If there ever was a time as Wyckoff said, to ‘completely ignore the financial press’, this may be that time.

He also stated, ‘reading price action is hard, taking literally decades and many losses to master’, a skill which is never really complete.

As the ‘About‘ section states, this site is one leader’s perspective on that action; presenting it, in a strategically cognizant form.

As far as is known, no other site is doing the same.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Newmont’s Decision … Down

May 25, 2024 By in Dr. Elder, GDX, GDXJ, Gold & Silver, Gold Miners, NEM, Speck-Effect, The Speck

Now, It Gets Interesting

Is it about to become a dumpster fire?

As usual, we have the rabid gold and silver bulls, breathless; ‘This is it!’, ‘This is the big one!’, ‘Dollar collapse, imminent!’

All the while, nobody’s reporting the fact, that ever since ‘The Speck’ was introduced in 2019, and of course, Speck ‘protection‘, gold production has dropped to 2014 levels, and has not recovered (source, Statista).

Is it as simple as ‘supply and demand’? Is the ‘inflation’ narrative, just another ruse?

Even as gold and silver are rising (for now), the mining sector’s GDX, GDXJ, are far below their all-time highs.

As if to put icing on the cake, Newmont, appears to have reversed (not advice, not a recommendation).

Newmont Mining NEM, Daily (inverted)

Similar to recent biotech analysis, we’re inverting the chart to show the potential.

Note: This ‘inversion’ technique is a psychological exercise covered in one of Dr. Elder’s books (here and here).

It’s a basic fundamental for un-biased analysis.

Back in the day, while publishing on SeekingAlpha (a whole story in itself), users of that site would complain about charts being ‘upside down’. 🙂

Moving on, we have the following:

There’s a lot going on in this chart.

Price action has recoiled off the support (resistance non-inverted) and is now at a point where it may attempt to retrace for a test.

MACD has become successively bullish; now has a crossover signal.

As shown in prior updates here and here, the support level’s in the vicinity of the 23.6%, retrace.

That indicates bullishness on the chart above or weakness on non-inverted (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Bearish Bet on Biotech

May 23, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-11, Prechter, SPBIO, The Maverick of Wall Street, The Speck, XBI

‘Monkey See … ‘

The next ‘show’ is about to begin; let’s take our seats, get the popcorn ready.

Setting the stage, we have this, just out.

Looks like there’s another ‘Speck’ on the horizon. You know, ‘The Thing’ as The Maverick of Wall Street, likes to call it.

But we can’t have this crisis go to waste. How about a press release, letting everyone know, we’re about to make (yet) another bundle of cash.

Is that really going to happen, this time around?

To find the answer or the probability, we’ll go to the chart of biotech XBI, and have it tell us the likely outcome.

Biotech XBI, Daily (inverted)

As we’ve being doing previously, here, and here, we’re using the daily but inverting it to show bearish (LABD) potential.

As a reminder, this update, indicated a possible stop for a short position (not advice, not a recommendation).

That location is labeled ‘Stop No. 1‘, on the chart.

Yesterday’s action presented the opportunity to move the stop; it’s labeled as ‘Stop No. 2‘.

Rule of Alternation

This ‘rule’, coming from Robert Prechter Jr., says:

‘What happened last time, is not likely to happen this time.’

That guides us to expect something different.

From the perspective of the analysis above, that ‘different’ is pointing probabilities to the downside (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Deep ‘Kimchi’ Update … Newmont

May 11, 2024 By in Gold & Silver, Gold Miners, Michael Bordenaro, NEM, SBUX, Speck-Effect, The Speck, Wyckoff, ZeroHedge 1 Comment

Setting Up For ‘Breakout’ or, ‘Digging-In’ …?

Gold’s near all-time highs, silver’s rebounded, testing recent highs; yet Newmont’s at a paltry 23.6%, retrace.

So, you tell me. What’s likely to happen to Newmont, if gold or silver head back lower, even just a little bit?

That dude in the picture, needs to keep on diggin’. 🙂

Wyckoff, In-The-Know

Years ago, Wyckoff told us not to pay any attention to the financial press, the local circus.

However, that does not mean he didn’t know what was going on. He did, and sometimes down to the penny.

We don’t know for sure what’s (really) happening with Newmont and the mining sector but among other things, it might have something to do with this, this, and this.

Even so, price action’s the truth; let’s look at our chief cook and bottle washer’s progress since the last update.

Newmont Mining NEM, Weekly

The chart has expanded the Force Index (middle panel) for better clarity.

Going back to the last update, it had this to say:

“A reasonable expectation is NEM, retraces, testing the wide bar and volume before continuing to the downside or moving back higher to a breakout.”

Price action has done exactly that. It came down to test the wide (4/25/24) bar and then back up to resistance, where we are now.

The only thing missing at this point, is the breakout or reversal (not advice, not a recommendation).

Show Me, The Money

Anyone with two Latte’s rubbing together, knows the economy may (already) be in full-blown collapse.

Anecdotal (and factual) evidence of that can be found here, here and here.

Adding, Nemont itself is not doing well as evidenced by this recent (February) article about dividend cuts, asset sales.

Seems like everybody’s looking around for cash.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Globe Life Crash … -45%, So Far …

April 11, 2024 By in Biotech, GL, MET, The Speck

‘Fraud’ Is The Narrative

Here’s the latest news (as of 2:03 p.m., EST), link here.

Note, the article says the shares ‘tumbled’ … hardly, it’s a crash … take a look at the chart, link here.

The life insurance sector, and more specifically Globe Life (GL) along with Met Life (MET), have been on the watch list for reasons discussed many times on this site.

The Biotech Link

Possibly related (correlated) to the life insurance industry is biotech.

We’ll discuss that sector, XBI, in an upcoming update. The synopsis is that XBI could make a brief new daily high today (or at the open tomorrow).

If so, it could put the sector in a minor up-thrust position, while still in an overall down trend.

More later.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

There Are No ‘Rate Cuts’

March 22, 2024 By in $SPSIBI, Appalachia's Homestead, Biotech, Dr. John Campbell, Ed Dowd, Federal Reserve, Greg Hunter, Interest Rates, LABD, Michael Bordenaro, SPBIO, Speck-Effect, The Speck, Uneducated Economist, Wyckoff, XBI 2 Comments

‘There Is No Spoon’

We’re in the surreal; like The Matrix.

YouTube content creators have noticed the public’s inability, refusal, and denial to recognize (or accept) the truth:

Michael Bordenaro; ‘everybody’s so weak, so sensitive, they can’t handle the facts.’

Patera, Appalachia’s Homestead; discussing her lineage (Cherokee) and history, seeing the similarities of today, applying the lessons; some are more concerned about her hair and makeup.

Then, Uneducated Economist; ‘no amount of wishing is going to bring events back to the way it was. It’s effectively a new construct.’

Interest Rate Ruse

The 40-year bull market in bonds is over; rates are not going lower, they’re going higher (not advice, not a recommendation).

Ignoring or refusing to recognize this (highly probable) truth when analyzing markets, is a potential strategic error.

The longer the ruse goes on, the more violent the reaction may be when the masses (finally) ‘awake’.

All of which brings us to biotech, XBI, SPBIO, $SPSIBI.

Biotech Truth

Truth about biotech is brutal; described here, here and here.

Exactly how this will all hit the mainstream in force, is unknown. However, let’s not forget, ‘when price action goes south, bad news comes out’.

Biotech XBI, Daily

Heading south at this point, is biotech XBI.

Market test of the Wyckoff up-thrust (reversal) appears complete; previously discussed here, here and here.

As of 1:40 p.m., EST, XBI is trading back into congestion (92 – 96) and looks to have formed a trading channel.

Left channel contact line shown as No. 1, is supported by this post, potential long-term reversal.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

When Costco Sells Gold

October 1, 2023 By in China, Food Supply, Genesis 41, GLD, GOLD, Gold & Silver, Gold Miners, serpentza, The List, The Speck, Wyckoff, ZeroHedge

The Mother of All Contrary Indicators

This has to be it, right?

Selling gold in a supermarket; an expensive commodity, peddled to the least informed and least capitalized segment of the public.

Once that market’s saturated, who’s left?

Going Down Memory Lane

It’s been nearly three years since this post.

From a long-term strategy standpoint, this site has been consistent; it’s the food supply first, then gold and silver (not advice, not a recommendation).

The next shoe has yet to drop on how or what’s going to be used to extract (or confiscate) precious metals from the (stacking) proletariat.

With craziness by the day, anything can happen.

Gold: Turning Points & Technical

So far, it’s been three-for-three (here, here and here) identifying recent significant technical conditions and turning points for gold, GLD.

At this juncture, the dollar collapse, and the silver/gold bull launch are just not happening. It’s not there … something else is going on (not advice, not a recommendation).

We’re in the middle of a massive sovereign bankruptcy (Time Stamp 7:10) that’s never happened before.

What’s going on behind the scenes is not visible to us.

However, from a Wyckoff analysis standpoint, those (hidden) actions and decisions show up on the chart(s).

Contrary Indicator

Remember Baghdad Bob?

Constantly giving press conferences discussing the strength of the military campaign when the exact opposite was true.

It may be so with gold as well (not advice, not a recommendation).

The local supermarket has decided, after a 22-year long bull market, it’s ‘safe’ for profit.

The hapless public is now standing at the gold kiosk; with face-mask firmly secured, arm bandaged from the latest booster, EV FOB in hand (or pocket), hypnotized into yet another mania.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Sector, Buckles

September 28, 2023 By in $SPSIBI, Biotech, LABD, Positions, SPBIO, Speck-Effect, The List, The Speck, ZeroHedge 1 Comment

Bad, And More Bad News

It’s been a little nerve-wracking over the past two sessions being short biotech; was it an upward correction, or a full-blown reversal?

No one really knows, until it’s over.

Well, as of today’s new daily low in index SPBIO, it looks like what is now seen as a correction, may be complete (not advice, not a recommendation).

Bad, And More Bad

On the fundamental side, The List keeps building with links like this, this and this.

However, keep in mind, it may be something as simple as rising interest rates that’s ultimately going to collapse biotech and the rest of the markets (not advice, not a recommendation).

Moving on and looking at the chart of SPBIO, there’s a trend confirmation and potential trading channel.

Biotech SPBIO, Daily

The left side line is the trend … the right-side line is what’s called the ‘reverse trendline’ and possibly defines the trading channel.

As of this post (12:30 p.m., EST) the SPBIO, is doing all it can to reverse higher, against what may be the over-riding (down) trend.

So far, the daily high of SPBIO 5764.73, remains intact.

Positioning

As a result of today’s new SPBIO low, the stop has been moved on the position in the inverse fund LABD, from LABD 18.22, to LABD 19.18 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279